You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Buparlisib

Showing 1 - 25 of 41
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head Neck Cancer Trial in Tyler (Buparlisib & Paclitaxel)

Recruiting
  • Head and Neck Cancer
  • Buparlisib & Paclitaxel
  • Tyler, Texas
    Hope Cancer Center, UT Health East Texas
Aug 11, 2022

Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Buparlisib, Ibrutinib)

Completed
  • Lymphoma
  • +3 more
  • Basking Ridge, New Jersey
  • +5 more
Oct 7, 2022

Metastatic Transitional Cell Carcinoma of the Urothelium Trial in United States (Buparlisib)

Completed
Has Results
  • Metastatic Transitional Cell Carcinoma of the Urothelium
  • Buparlisib
  • Basking Ridge, New Jersey
  • +4 more
May 26, 2021

Brain Metastases, Breast Cancer, Metastatic Breast Cancer Trial in Multiple Locations (BKM120, capecitabine, Trastuzumab)

Completed
Has Results
  • Brain Metastases
  • +2 more
  • Multiple Locations, Texas
    Please contact Zuzanne Bristow for list of sites
Jan 31, 2022

Carcinoma, Squamous Cell of Head and Neck, HPV Positive Oropharyngeal Squamous Cell Carcinoma, Hypopharyngeal Cancer Trial in

Completed
  • Carcinoma, Squamous Cell of Head and Neck
  • +5 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 24, 2022

Renal Impairment Trial in Worldwide (Buparlisib)

Completed
  • Renal Impairment
  • Buparlisib
  • Sofia, Bulgaria
  • +3 more
Dec 6, 2020

Recurrent Glioblastoma Multiforme Trial in Worldwide (buparlisib, carboplatin, lomustine)

Completed
  • Recurrent Glioblastoma Multiforme
  • buparlisib
  • +3 more
  • Phoenix, Arizona
  • +13 more
Dec 6, 2020

Advanced or Metastatic Breast Cancer Trial in Spain, United States (LEE011, Buparlisib, Letrozole)

Completed
  • Advanced or Metastatic Breast Cancer
  • Los Angeles, California
  • +5 more
Dec 16, 2020

High Risk Prostate Cancer Trial in San Francisco (BKM120)

Terminated
Has Results
  • High Risk Prostate Cancer
  • San Francisco, California
    University of California, San Francisco
Jan 7, 2021

Chronic Lymphocytic Leukemia Trial in Canada (Buparlisib)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Buparlisib
  • Calgary, Alberta, Canada
  • +5 more
Apr 28, 2020

Pre-menopausal Breast Cancer, PI3K Pathway Inhibition Trial in Worldwide (alpelisib (BYL719), buparlisib (BKM120))

Completed
  • Pre-menopausal Breast Cancer
  • PI3K Pathway Inhibition
  • alpelisib (BYL719)
  • buparlisib (BKM120)
  • Hong Kong, Hong Kong
  • +14 more
Mar 5, 2020

Glioblastoma Multiforme Trial in United States (Bevacizumab, BKM120)

Completed
Has Results
  • Glioblastoma Multiforme
  • New Haven, Connecticut
  • +7 more
Jun 8, 2020

Carcinoma, Basal Cell, Recurrent Skin Cancer, Skin Tumors Trial in Stanford (Buparlisib, Sonidegib)

Terminated
Has Results
  • Carcinoma, Basal Cell
  • +3 more
  • Stanford, California
    Stanford University School of Medicine
Jan 10, 2019

Non-Small Cell Lunch Cancer Trial in Worldwide (Buparlisib, Buparlisib , Carboplatin)

Terminated
  • Non-Small Cell Lunch Cancer
  • Buparlisib
  • +3 more
  • Fayetteville, Arkansas
  • +6 more
Oct 9, 2018

Head and Neck Tumors, Tumor Metastasis, Recurrent Disease Trial in France (BKM120)

Completed
  • Head and Neck Neoplasms
  • +3 more
  • Bordeaux, France
  • +8 more
Jun 20, 2019

Breast Cancer Trial in Boston (BKM120)

Completed
Has Results
  • Breast Cancer
  • Boston, Massachusetts
  • +3 more
Jan 17, 2019

Squamous NSCLC Trial in Worldwide (Buparlisib, Buparlisib matching , Docetaxel)

Terminated
  • Squamous Non-small Cell Lung Cancer
  • Buparlisib
  • +2 more
  • Fayetteville, Arkansas
  • +15 more
Aug 12, 2018

Non Small Cell Lung Cancer Trial in United States (BKM120 and Erlotinib)

Completed
Has Results
  • Non Small Cell Lung Cancer
  • BKM120 and Erlotinib
  • Fort Myers, Florida
  • +6 more
Feb 25, 2019

Breast Cancer Trial in Worldwide (Fulvestrant, BKM120, BKM120 matching )

Completed
Has Results
  • Breast Cancer
  • Mobile, Alabama
  • +267 more
Aug 24, 2020

Solid Tumors Trial in Milano (BKM120-CIS, BKM120-CARBO)

Completed
  • Solid Tumors
  • Milano, MI, Italy
    Ospedale San Raffaele
Jun 18, 2018

c-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280,

Terminated
Has Results
  • c-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBM
  • Boston, Massachusetts
  • +12 more
May 29, 2018

A Disease Registry of Patients With Mantle Cell Lymphoma

Active, not recruiting
  • Mantle Cell Lymphoma
    • Montgomery, Alabama
    • +33 more
    Oct 28, 2022

    Breast Cancer Trial in Freiburg (BKM120, Tamoxifen)

    Completed
    • Breast Cancer
    • Freiburg, Baden-Württemberg, Germany
      iOMEDICO AG
    Apr 19, 2018

    Breast Cancer Trial in Singapore (Lenvatinib + Letrozole, Fulvestrant)

    Not yet recruiting
    • Breast Cancer
    • Singapore, Singapore
      Nationa University Hospital
    Jan 4, 2022

    Head and Neck Squamous Cell Carcinoma Trial in Worldwide (Buparlisib, Buparlisib matching Placebo, Paclitaxel)

    Terminated
    Has Results
    • Head and Neck Squamous Cell Carcinoma
    • Buparlisib
    • +2 more
    • Fayetteville, Arkansas
    • +57 more
    Jun 26, 2018